{"id":"https://openalex.org/W2136971046","doi":"https://doi.org/10.1128/jb.01103-12","title":"Novel Rapidly Diversifiable Antimicrobial RNA Polymerase Switch Region Inhibitors with Confirmed Mode of Action in Haemophilus influenzae","display_name":"Novel Rapidly Diversifiable Antimicrobial RNA Polymerase Switch Region Inhibitors with Confirmed Mode of Action in Haemophilus influenzae","publication_year":2012,"publication_date":"2012-07-29","ids":{"openalex":"https://openalex.org/W2136971046","doi":"https://doi.org/10.1128/jb.01103-12","mag":"2136971046","pmid":"https://pubmed.ncbi.nlm.nih.gov/22843845","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3458661"},"language":"en","primary_location":{"id":"doi:10.1128/jb.01103-12","doi":"https://doi.org/10.1128/jb.01103-12","is_oa":false,"landing_page_url":"https://doi.org/10.1128/jb.01103-12","pdf_url":null,"source":{"id":"https://openalex.org/S133274750","display_name":"Journal of Bacteriology","issn_l":"0021-9193","issn":["0021-9193","1067-8832","1098-5530"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Bacteriology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3458661","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112785864","display_name":"Ed T. Buurman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ed T. Buurman","raw_affiliation_strings":["Departments of Bioscience, AstraZeneca R&amp;D Boston, Infection Innovative Medicines Unit, Waltham, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Bioscience, AstraZeneca R&amp;D Boston, Infection Innovative Medicines Unit, Waltham, Massachusetts, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021804052","display_name":"Melinda A. Foulk","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melinda A. Foulk","raw_affiliation_strings":["Chemistry, AstraZeneca R&amp;D Boston, Infection Innovative Medicines Unit, Waltham, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemistry, AstraZeneca R&amp;D Boston, Infection Innovative Medicines Unit, Waltham, Massachusetts, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019513616","display_name":"Ning Gao","orcid":"https://orcid.org/0000-0003-1605-4137","observed_orcids":["https://orcid.org/0000-0003-1605-4137"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ning Gao","raw_affiliation_strings":["Departments of Bioscience, AstraZeneca R&amp;D Boston, Infection Innovative Medicines Unit, Waltham, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Bioscience, AstraZeneca R&amp;D Boston, Infection Innovative Medicines Unit, Waltham, Massachusetts, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083692015","display_name":"Valerie A. Laganas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Valerie A. Laganas","raw_affiliation_strings":["Departments of Bioscience, AstraZeneca R&amp;D Boston, Infection Innovative Medicines Unit, Waltham, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Bioscience, AstraZeneca R&amp;D Boston, Infection Innovative Medicines Unit, Waltham, Massachusetts, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025449166","display_name":"David C. McKinney","orcid":"https://orcid.org/0000-0003-1787-1841","observed_orcids":["https://orcid.org/0000-0003-1787-1841"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David C. McKinney","raw_affiliation_strings":["Chemistry, AstraZeneca R&amp;D Boston, Infection Innovative Medicines Unit, Waltham, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemistry, AstraZeneca R&amp;D Boston, Infection Innovative Medicines Unit, Waltham, Massachusetts, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056284392","display_name":"Demetri T. Moustakas","orcid":"https://orcid.org/0009-0000-1302-4042","observed_orcids":["https://orcid.org/0009-0000-1302-4042"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Demetri T. Moustakas","raw_affiliation_strings":["Chemistry, AstraZeneca R&amp;D Boston, Infection Innovative Medicines Unit, Waltham, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemistry, AstraZeneca R&amp;D Boston, Infection Innovative Medicines Unit, Waltham, Massachusetts, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jonathan A. Rose","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan A. Rose","raw_affiliation_strings":["Chemistry, AstraZeneca R&amp;D Boston, Infection Innovative Medicines Unit, Waltham, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemistry, AstraZeneca R&amp;D Boston, Infection Innovative Medicines Unit, Waltham, Massachusetts, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090436170","display_name":"Adam B. Shapiro","orcid":"https://orcid.org/0000-0002-2662-6146","observed_orcids":["https://orcid.org/0000-0002-2662-6146"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adam B. Shapiro","raw_affiliation_strings":["Departments of Bioscience, AstraZeneca R&amp;D Boston, Infection Innovative Medicines Unit, Waltham, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Bioscience, AstraZeneca R&amp;D Boston, Infection Innovative Medicines Unit, Waltham, Massachusetts, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"last","author":{"id":null,"display_name":"Paul R. Fleming","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul R. Fleming","raw_affiliation_strings":["Chemistry, AstraZeneca R&amp;D Boston, Infection Innovative Medicines Unit, Waltham, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemistry, AstraZeneca R&amp;D Boston, Infection Innovative Medicines Unit, Waltham, Massachusetts, USA","institution_ids":["https://openalex.org/I4210150756"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210150756"],"apc_list":null,"apc_paid":null,"fwci":2.51,"has_fulltext":false,"cited_by_count":29,"citation_normalized_percentile":{"value":0.89954392,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"194","issue":"20","first_page":"5504","last_page":"5512"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10120","display_name":"Bacterial Genetics and Biotechnology","score":0.35179999470710754,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10120","display_name":"Bacterial Genetics and Biotechnology","score":0.35179999470710754,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.29030001163482666,"subfield":{"id":"https://openalex.org/subfields/1313","display_name":"Molecular Medicine"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12526","display_name":"Antimicrobial agents and applications","score":0.08320000022649765,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/squaramides","display_name":"squaramides","score":0.746999979019165},{"id":"https://openalex.org/keywords/rna-polymerase-inhibitors","display_name":"RNA polymerase inhibitors","score":0.9629999995231628},{"id":"https://openalex.org/keywords/switch-regions","display_name":"switch regions","score":0.6909999847412109},{"id":"https://openalex.org/keywords/haemophilus-influenzae","display_name":"Haemophilus influenzae","score":0.9139999747276306},{"id":"https://openalex.org/keywords/escherichia-coli","display_name":"Escherichia coli","score":0.9789999723434448},{"id":"https://openalex.org/keywords/rpob-gene","display_name":"rpoB","score":0.7020000219345093},{"id":"https://openalex.org/keywords/rpoc","display_name":"rpoC","score":0.9909999966621399},{"id":"https://openalex.org/keywords/transcription-inhibition","display_name":"transcription inhibition","score":0.4819999933242798},{"id":"https://openalex.org/keywords/fidaxomicin","display_name":"fidaxomicin","score":0.9240000247955322},{"id":"https://openalex.org/keywords/rifampicin-resistance","display_name":"rifampicin resistance","score":0.6460000276565552},{"id":"https://openalex.org/keywords/cross-resistance","display_name":"cross-resistance","score":0.6880000233650208},{"id":"https://openalex.org/keywords/antibiotic-resistance-mutations","display_name":"antibiotic resistance mutations","score":0.4970000088214874},{"id":"https://openalex.org/keywords/antibacterial-agents","display_name":"antibacterial agents","score":0.4480000138282776}],"concepts":[{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.815951943397522},{"id":"https://openalex.org/C2776449523","wikidata":"https://www.wikidata.org/wiki/Q272631","display_name":"RNA polymerase","level":4,"score":0.682459831237793},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.5390180349349976},{"id":"https://openalex.org/C179926584","wikidata":"https://www.wikidata.org/wiki/Q207714","display_name":"Transcription (linguistics)","level":2,"score":0.4972553551197052},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.4460589587688446},{"id":"https://openalex.org/C64350747","wikidata":"https://www.wikidata.org/wiki/Q15334993","display_name":"RNA polymerase II","level":5,"score":0.44117191433906555},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.43604010343551636},{"id":"https://openalex.org/C41258723","wikidata":"https://www.wikidata.org/wiki/Q2919111","display_name":"RNA-dependent RNA polymerase","level":4,"score":0.41750502586364746},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.37758976221084595},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.32544416189193726},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.23353680968284607},{"id":"https://openalex.org/C101762097","wikidata":"https://www.wikidata.org/wiki/Q224093","display_name":"Promoter","level":4,"score":0.1771213710308075},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.15974459052085876},{"id":"https://openalex.org/C41895202","wikidata":"https://www.wikidata.org/wiki/Q8162","display_name":"Linguistics","level":1,"score":0.0},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D004926","descriptor_name":"Escherichia coli","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004926","descriptor_name":"Escherichia coli","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D006193","descriptor_name":"Haemophilus influenzae","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006193","descriptor_name":"Haemophilus influenzae","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":true},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008958","descriptor_name":"Models, Molecular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011487","descriptor_name":"Protein Conformation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012293","descriptor_name":"Rifampin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012321","descriptor_name":"DNA-Directed RNA Polymerases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D012321","descriptor_name":"DNA-Directed RNA Polymerases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D024881","descriptor_name":"Drug Resistance, Bacterial","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D050505","descriptor_name":"Mutant Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D050505","descriptor_name":"Mutant Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D057166","descriptor_name":"High-Throughput Screening Assays","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1128/jb.01103-12","doi":"https://doi.org/10.1128/jb.01103-12","is_oa":false,"landing_page_url":"https://doi.org/10.1128/jb.01103-12","pdf_url":null,"source":{"id":"https://openalex.org/S133274750","display_name":"Journal of Bacteriology","issn_l":"0021-9193","issn":["0021-9193","1067-8832","1098-5530"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Bacteriology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2610439","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3458661","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3458661","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3458661","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Bacteriol","raw_type":"Text"},{"id":"pmid:22843845","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22843845","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of bacteriology","raw_type":"Journal Article"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:2610439","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3458661","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"score":0.504800021648407,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W611976593","https://openalex.org/W1566790738","https://openalex.org/W1598844438","https://openalex.org/W1970798262","https://openalex.org/W1980640885","https://openalex.org/W1982183474","https://openalex.org/W1982941851","https://openalex.org/W2008083853","https://openalex.org/W2016824226","https://openalex.org/W2024050097","https://openalex.org/W2029978813","https://openalex.org/W2030551247","https://openalex.org/W2036194106","https://openalex.org/W2068372433","https://openalex.org/W2081394599","https://openalex.org/W2084622414","https://openalex.org/W2097250061","https://openalex.org/W2100195325","https://openalex.org/W2114167010","https://openalex.org/W2126678004","https://openalex.org/W2131704003","https://openalex.org/W2142524709","https://openalex.org/W2143095073","https://openalex.org/W2151952082","https://openalex.org/W2153146450","https://openalex.org/W2155981324","https://openalex.org/W2164025050","https://openalex.org/W2174331966","https://openalex.org/W2332678502","https://openalex.org/W2743041357"],"related_works":["https://openalex.org/W2326375040","https://openalex.org/W2029978813","https://openalex.org/W7052832661","https://openalex.org/W2327235914","https://openalex.org/W1982183474","https://openalex.org/W2071310532","https://openalex.org/W4243113462","https://openalex.org/W2333306656","https://openalex.org/W2137749088","https://openalex.org/W2002592515"],"abstract_inverted_index":{"A":[0],"series":[1,60],"of":[2,20,53,67,80,105,116,124,143,148,155,181],"inhibitors":[3,19,31,157,175],"with":[4,40,45,161],"a":[5,14,21,152],"squaramide":[6],"core":[7],"was":[8,38,48],"synthesized":[9],"following":[10],"its":[11],"discovery":[12],"in":[13,103],"high-throughput":[15],"screen":[16],"for":[17],"novel":[18],"transcription-coupled":[22],"translation":[23],"assay":[24],"using":[25,138],"Escherichia":[26],"coli":[27,56,69],"S30":[28],"extracts.":[29],"The":[30,59,165],"were":[32,93,101],"inactive":[33],"when":[34],"the":[35,75,112,121,125,133,139,144,162,168,178],"plasmid":[36],"substrate":[37],"replaced":[39],"mRNA,":[41],"suggesting":[42],"they":[43],"interfered":[44],"transcription.":[46],"This":[47,119],"confirmed":[49],"by":[50],"their":[51],"inhibition":[52],"purified":[54],"E.":[55,68],"RNA":[57,81,117,146,182],"polymerase.":[58,118,183],"had":[61],"antimicrobial":[62],"activity":[63],"against":[64],"efflux-negative":[65],"strains":[66],"and":[70,82,88,130,132],"Haemophilus":[71],"influenzae.":[72],"Like":[73],"rifampin,":[74],"squaramides":[76,166],"preferentially":[77],"inhibited":[78],"synthesis":[79],"protein":[83],"over":[84],"fatty":[85],"acids,":[86],"peptidoglycan,":[87],"DNA.":[89],"However,":[90],"squaramide-resistant":[91],"mutants":[92],"not":[94],"cross-resistant":[95],"to":[96],"rifampin.":[97],"Nine":[98],"different":[99],"mutations":[100],"found":[102],"parts":[104],"rpoB":[106],"or":[107],"rpoC":[108],"that":[109,158],"together":[110],"encode":[111],"so-called":[113],"switch":[114,179],"region":[115,180],"is":[120,159],"binding":[122,153],"site":[123],"natural":[126],"antibiotics":[127],"myxopyronin,":[128],"corallopyronin,":[129],"ripostatin":[131],"drug":[134],"fidaxomicin.":[135],"Computational":[136],"modeling":[137],"X-ray":[140],"crystal":[141],"structure":[142],"myxopyronin-bound":[145],"polymerase":[147],"Thermus":[149],"thermophilus":[150],"suggests":[151],"mode":[154],"these":[156],"consistent":[160],"resistance":[163],"mutations.":[164],"are":[167],"first":[169],"reported":[170],"non-natural-product-related,":[171],"rapidly":[172],"diversifiable":[173],"antibacterial":[174],"acting":[176],"via":[177]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}
